osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
Published 4 years ago • 2K plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
15:35
asco 2020: latest developments in egfr-mutated non-small cell lung cancer
-
2:20
osimertinib in advanced non–small-cell lung cancer
-
3:02
osimertinib for treating non-small cell lung cancer
-
1:36
comment: front-line osimertinib significantly lengthens overall survival in egfr-mutation positi...
-
2:20
osimertinib with chemotherapy in egfr-mutated nsclc | nejm
-
2:21
osimertinib ipilimumab in egfr-mutated nsclc
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer
-
9:54
amivantamab combo with lazertinib favourable in post-osimertinib egfr-mutant nsclc
-
5:03
adaura results: adjuvant osimertinib for egfrm non-small cell lung cancer
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
5:55
a case of egfr-mutant non–small cell lung cancer
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
5:57
dr rajesh patidar | furmonertinib versus gefitinib in treatment naïve egfr mutated non small cell
-
3:54
adding gefitinib to conventional therapy of patients with egfr-mutant non-small cell lung cancer
-
6:28
sequential treatment with afatinib and osimertinib in patients with egfr mutation-positive nsclc
-
7:00
researcher comment: dual egfr inhibition for egfr-mutated nsclc | julia rotow
-
0:55
osimertinib for egfr-mutant lung cancer
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc